HUP0103265A3 - Cyclic prosaposin-derived peptides, pharmaceutical compositions comprising thereof and their use - Google Patents
Cyclic prosaposin-derived peptides, pharmaceutical compositions comprising thereof and their useInfo
- Publication number
- HUP0103265A3 HUP0103265A3 HU0103265A HUP0103265A HUP0103265A3 HU P0103265 A3 HUP0103265 A3 HU P0103265A3 HU 0103265 A HU0103265 A HU 0103265A HU P0103265 A HUP0103265 A HU P0103265A HU P0103265 A3 HUP0103265 A3 HU P0103265A3
- Authority
- HU
- Hungary
- Prior art keywords
- pharmaceutical compositions
- derived peptides
- prosaposin
- cyclic
- cyclic prosaposin
- Prior art date
Links
- 102100036197 Prosaposin Human genes 0.000 title 1
- 101710152403 Prosaposin Proteins 0.000 title 1
- 125000004122 cyclic group Chemical group 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9835998P | 1998-08-28 | 1998-08-28 | |
| PCT/US1999/019378 WO2000012553A1 (en) | 1998-08-28 | 1999-08-20 | Cyclic prosaposin-derived peptides and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0103265A2 HUP0103265A2 (hu) | 2002-02-28 |
| HUP0103265A3 true HUP0103265A3 (en) | 2002-09-30 |
Family
ID=22268937
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0103265A HUP0103265A3 (en) | 1998-08-28 | 1999-08-20 | Cyclic prosaposin-derived peptides, pharmaceutical compositions comprising thereof and their use |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1105420A1 (https=) |
| JP (2) | JP4528443B2 (https=) |
| KR (1) | KR20010079695A (https=) |
| CN (1) | CN1324367A (https=) |
| AU (1) | AU751034B2 (https=) |
| BR (1) | BR9913490A (https=) |
| CA (1) | CA2341810A1 (https=) |
| CZ (1) | CZ2001655A3 (https=) |
| HU (1) | HUP0103265A3 (https=) |
| IL (1) | IL141586A0 (https=) |
| PL (1) | PL204359B1 (https=) |
| WO (1) | WO2000012553A1 (https=) |
| ZA (1) | ZA200102489B (https=) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5571787A (en) | 1993-07-30 | 1996-11-05 | Myelos Corporation | Prosaposin as a neurotrophic factor |
| IL141586A0 (en) * | 1998-08-28 | 2002-03-10 | Myelos Corp | Cyclic prosaposin-derived peptide and uses thereof |
| AUPQ084899A0 (en) * | 1999-06-08 | 1999-07-01 | University Of Melbourne, The | Neurotrophin agonists |
| IL137820A (en) * | 2000-08-10 | 2009-06-15 | S I S Shulov Inst For Science | Pharmaceutical composition for topical administration comprising an analgesic peptide |
| CN100366286C (zh) * | 2003-04-28 | 2008-02-06 | 常州南云科技有限公司 | Saposin C-DOPS:一种抗癌新药 |
| ES2641272T3 (es) | 2006-04-28 | 2017-11-08 | Children's Hospital Medical Center | Composiciones que comprenden proteínas o polipéptidos fusogénicos derivados de la prosaposina para aplicación en sistemas de suministro de fármacos transmembrana |
| JP5253402B2 (ja) * | 2006-10-20 | 2013-07-31 | チルドレンズ ホスピタル メディカル センター | 自発的に形成する楕円体の単層リン脂質小胞 |
| CN103275187B (zh) * | 2013-06-14 | 2014-10-29 | 四川合泰新光生物科技有限公司 | 一种镇痛肽fi及其基因和应用 |
| WO2016172409A1 (en) | 2015-04-23 | 2016-10-27 | The Procter & Gamble Company | Delivery of surfactant soluble anti-dandruff agent |
| MX379907B (es) | 2016-03-03 | 2025-03-11 | Procter & Gamble | Composicion anticaspa en aerosol. |
| WO2018075846A1 (en) | 2016-10-21 | 2018-04-26 | The Procter & Gamble Company | Concentrated shampoo dosage of foam designating hair conditioning benefits |
| BR112019007682B1 (pt) | 2016-10-21 | 2022-08-16 | The Procter & Gamble Company | Produtos de xampu compactos estáveis com baixa viscosidade e agente redutor de viscosidade |
| EP3528896A1 (en) | 2016-10-21 | 2019-08-28 | The Procter & Gamble Company | Concentrated shampoo dosage of foam for providing hair care benefits |
| CN109862944A (zh) | 2016-10-21 | 2019-06-07 | 宝洁公司 | 用于以最佳制剂空间递送消费者所需的剂型体积和表面活性剂量的泡沫剂型 |
| EP3528774A1 (en) | 2016-10-21 | 2019-08-28 | The Procter and Gamble Company | Concentrated shampoo dosage of foam designating hair volume benefits |
| EP3528894A1 (en) | 2016-10-21 | 2019-08-28 | The Procter and Gamble Company | Concentrated shampoo dosage of foam for providing hair care benefits |
| CN109843383A (zh) | 2016-10-21 | 2019-06-04 | 宝洁公司 | 用于在最佳制剂空间中递送消费者期望的剂量体积、表面活性剂量和头皮健康剂量的泡沫剂型 |
| US11141370B2 (en) | 2017-06-06 | 2021-10-12 | The Procter And Gamble Company | Hair compositions comprising a cationic polymer mixture and providing improved in-use wet feel |
| US11679073B2 (en) | 2017-06-06 | 2023-06-20 | The Procter & Gamble Company | Hair compositions providing improved in-use wet feel |
| US11224567B2 (en) | 2017-06-06 | 2022-01-18 | The Procter And Gamble Company | Hair compositions comprising a cationic polymer/silicone mixture providing improved in-use wet feel |
| MX388495B (es) | 2017-10-10 | 2025-03-20 | Procter & Gamble | Composición de champú compacto que contiene surfactantes libres de sulfato. |
| CN111278418A (zh) | 2017-10-10 | 2020-06-12 | 宝洁公司 | 具有基于氨基酸的阴离子表面活性剂和阳离子聚合物的致密型洗发剂组合物 |
| CN111278416A (zh) | 2017-10-10 | 2020-06-12 | 宝洁公司 | 含低无机盐的无硫酸盐个人清洁组合物 |
| EP3694479B1 (en) | 2017-10-10 | 2026-01-14 | The Procter & Gamble Company | A method of treating hair or skin with a personal care composition in a foam form |
| EP3727323B1 (en) | 2017-12-20 | 2026-04-29 | The Procter & Gamble Company | Clear shampoo composition containing silicone polymers |
| US11318073B2 (en) | 2018-06-29 | 2022-05-03 | The Procter And Gamble Company | Low surfactant aerosol antidandruff composition |
| US12226505B2 (en) | 2018-10-25 | 2025-02-18 | The Procter & Gamble Company | Compositions having enhanced deposition of surfactant-soluble anti-dandruff agents |
| CN114746153A (zh) | 2019-12-06 | 2022-07-12 | 宝洁公司 | 具有增强头皮活性物质沉积的不含硫酸盐的组合物 |
| CN115151310B (zh) | 2020-02-27 | 2024-12-20 | 宝洁公司 | 功效和美观性增强的含硫去头皮屑组合物 |
| CA3198853A1 (en) | 2020-11-23 | 2022-05-27 | The Procter & Gamble Company | Personal care compositions free of sulfated surfactants |
| MX2023005963A (es) | 2020-12-04 | 2023-06-07 | Procter & Gamble | Composiciones para el cuidado del cabello que comprenden materiales de reduccion del mal olor. |
| US11771635B2 (en) | 2021-05-14 | 2023-10-03 | The Procter & Gamble Company | Shampoo composition |
| US11986543B2 (en) | 2021-06-01 | 2024-05-21 | The Procter & Gamble Company | Rinse-off compositions with a surfactant system that is substantially free of sulfate-based surfactants |
| CA3235522A1 (en) | 2021-12-09 | 2023-06-15 | The Procter & Gamble Company | Sulfate free personal cleansing composition comprising effective preservation |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL106106A0 (en) * | 1993-06-22 | 1993-10-20 | Interpharm Lab Ltd | Library of polymeric molecules and its preparation |
| US6271196B1 (en) * | 1996-03-05 | 2001-08-07 | Regents Of The University Of Ca | Methods of alleviating neuropathic pain using prosaposin-derived peptides |
| IL141586A0 (en) * | 1998-08-28 | 2002-03-10 | Myelos Corp | Cyclic prosaposin-derived peptide and uses thereof |
-
1999
- 1999-08-20 IL IL14158699A patent/IL141586A0/xx not_active IP Right Cessation
- 1999-08-20 CZ CZ2001655A patent/CZ2001655A3/cs unknown
- 1999-08-20 HU HU0103265A patent/HUP0103265A3/hu unknown
- 1999-08-20 BR BR9913490-0A patent/BR9913490A/pt not_active IP Right Cessation
- 1999-08-20 AU AU56905/99A patent/AU751034B2/en not_active Ceased
- 1999-08-20 CA CA002341810A patent/CA2341810A1/en not_active Abandoned
- 1999-08-20 CN CN99812627A patent/CN1324367A/zh active Pending
- 1999-08-20 KR KR1020017002478A patent/KR20010079695A/ko not_active Withdrawn
- 1999-08-20 JP JP2000567569A patent/JP4528443B2/ja not_active Expired - Fee Related
- 1999-08-20 PL PL346346A patent/PL204359B1/pl not_active IP Right Cessation
- 1999-08-20 EP EP99943903A patent/EP1105420A1/en not_active Withdrawn
- 1999-08-20 WO PCT/US1999/019378 patent/WO2000012553A1/en not_active Ceased
-
2001
- 2001-03-27 ZA ZA200102489A patent/ZA200102489B/en unknown
-
2010
- 2010-02-19 JP JP2010034833A patent/JP2010150272A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU751034B2 (en) | 2002-08-08 |
| WO2000012553A1 (en) | 2000-03-09 |
| JP2010150272A (ja) | 2010-07-08 |
| HUP0103265A2 (hu) | 2002-02-28 |
| AU5690599A (en) | 2000-03-21 |
| EP1105420A1 (en) | 2001-06-13 |
| KR20010079695A (ko) | 2001-08-22 |
| JP4528443B2 (ja) | 2010-08-18 |
| JP2002523518A (ja) | 2002-07-30 |
| CA2341810A1 (en) | 2000-03-09 |
| CZ2001655A3 (cs) | 2001-11-14 |
| IL141586A0 (en) | 2002-03-10 |
| ZA200102489B (en) | 2002-06-04 |
| BR9913490A (pt) | 2001-09-25 |
| PL204359B1 (pl) | 2010-01-29 |
| CN1324367A (zh) | 2001-11-28 |
| PL346346A1 (en) | 2002-02-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0103265A3 (en) | Cyclic prosaposin-derived peptides, pharmaceutical compositions comprising thereof and their use | |
| HUP0103884A3 (en) | Arylsulfonanilide urea-derivatives, pharmaceutical compositions containing them and their use | |
| HUP0204514A3 (en) | Pyridinylimidazoles, pharmaceutical compositions containing them and their use | |
| HUP0204081A3 (en) | 4-pyrimidinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use | |
| ZA200110022B (en) | Thiazoloderivatives and pharmaceutical compositions containing them. | |
| IL142531A0 (en) | Cyclic peptide compound, processes for the preparation thereof and pharmaceutical compositions containing the same | |
| HUP0102372A3 (en) | Dihydropyrimidines, preparation thereof and pharmaceutical compositions containing the same | |
| HUP0103793A3 (en) | N-(2-aryl-propionyl)-sulfonamids, their use and pharmaceutical preparations containing them | |
| HUP0302969A3 (en) | Npyy5 antagonists, pharmaceutical compositions containing them and their use | |
| IL138280A0 (en) | 20-KETO-11β-ARYLSTERIODS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF | |
| HUP0102579A3 (en) | Peptide antiangiogenic drugs, pharmaceutical compositions comprising thereof and their use | |
| IL144910A0 (en) | Cyclic compounds and pharmaceutical compositions containing the same | |
| HUP0301573A3 (en) | Substituted arylpyrazines, pharmaceutical compositions containing them and their use | |
| HUP0003592A3 (en) | Lh-rh peptide analogues, their use and pharmaceutical compositions containing them | |
| HUP0203194A3 (en) | Phenylpiperazines, pharmaceutical compositions containing them and their use | |
| HUP0203735A3 (en) | 4-pyridinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use | |
| HUP0400967A3 (en) | Substituted 2-anilino-benzimidazoles, their use and pharmaceutical compositions containing them | |
| HUP0102515A3 (en) | Cyclopeptides, process for their preparation, pharmaceutical compositions comprising thereof and their use | |
| NZ305735A (en) | Cyclic peptide antifungal agents, preparation and pharmaceutical compositions thereof | |
| HUP0400179A3 (en) | 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines, their use and pharmaceutical compositions containing them | |
| HUP0004561A3 (en) | Dihydrobenzofurans, pharmaceutical compositions containing them and use thereof | |
| HUP9802132A3 (en) | Biphenyl-sulfonyl-cyanamides, their use and pharmaceutical compositions containing them | |
| HUP0200055A3 (en) | 16-hydroxyestrienes and pharmaceutical compositions containing the same | |
| HUP0104834A3 (en) | Sulphonyloxazolamines, their use, pharmaceutical compositions containing them and their preparation | |
| HUP0203627A3 (en) | N-guanidinoalkylamides, their preparation, their use, and pharmaceutical compositions comprising them |